Industry Innovation Series: Frontiers in Infectious Diseases Innovation

The final event in the 2025 Industry Innovation Series, ‘Frontiers in Infectious Diseases Innovation,’ offered attendees - across industry and academia - a unique opportunity to explore pioneering advances in infectious disease solutions and collaborative opportunities. Hosted in La Trobe University’s innovation centre, Eagleworks, on the Melbourne Campus, it was an evening of insightful discussion and networking, and highlighted the critical role of innovation in shaping the future of disease prevention and treatment. Speakers • Richard Alm PhD, Chief Scientific Officer, CARB-X Topic: CARB-X – Accelerating the Development of Novel Products to Tackle AMR • Emeritus Professor Marilyn Anderson, Founding Scientist, Deftbiotech Topic: A new drug for treatment of fungal diseases • Dr Felicia Pradera, Director, Moderna (Regional Research Centre and Strategic Alliances) Topic: mRNA Technology: Advancing Innovation in Infectious Diseases • Professor Begoña Heras, Co-Founder and CEO, BioBreak Therapeutics Topic: Novel therapeutics for recurrent and chronic urinary tract infections This session recording features an hour of expert-led presentations, followed by a panel discussion and interactive audience Q&A. To stay up to date with La Trobe Industry events, follow La Trobe Industry on LinkedIn: https://www.linkedin.com/company/la-trobe-industry or Eventbrite: https://www.eventbrite.com.au/o/la-trobe-industry-38603283573